Regeneron (REGN) Tops Q1 EPS by $1.45
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $735.20 +0.05%
Revenue Growth %: +21.1%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
TAYD, PKE, More
Revenue Growth %: +21.1%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $11.49, $1.45 better than the analyst estimate of $10.04. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.73 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
- Reaction roundup: Experts, analysts weigh in on September jobs report
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
